XML 29 R14.htm IDEA: XBRL DOCUMENT
v3.22.1

Other Accrued Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2021
Payables And Accruals [Abstract] |
Other Accrued Liabilities |
6. | Other Accrued Liabilities
Other accrued liabilities consisted of the following (in thousands):
|  | Year Ended December 31, |
|  | 2021 |  |  | 2020 |
Manufacturing |  | $ | 1,381 |  |  | $ | 2,238 |
Biogen |  |  | 868 |  |  |  | — |
Pre-clinical |  |  | 773 |  |  |  | — |
Professional and consulting services |  |  | 509 |  |  |  | 3,979 |
Clinical |  |  | 361 |  |  |  | 291 |
Other |  |  | 180 |  |  |  | 235 |
Total other accrued liabilities |  | $ | 4,072 |  |  | $ | 6,743 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration